Correlation Between AIM ImmunoTech and Enbridge

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AIM ImmunoTech and Enbridge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AIM ImmunoTech and Enbridge into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AIM ImmunoTech and Enbridge, you can compare the effects of market volatilities on AIM ImmunoTech and Enbridge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AIM ImmunoTech with a short position of Enbridge. Check out your portfolio center. Please also check ongoing floating volatility patterns of AIM ImmunoTech and Enbridge.

Diversification Opportunities for AIM ImmunoTech and Enbridge

-0.92
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between AIM and Enbridge is -0.92. Overlapping area represents the amount of risk that can be diversified away by holding AIM ImmunoTech and Enbridge in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enbridge and AIM ImmunoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AIM ImmunoTech are associated (or correlated) with Enbridge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enbridge has no effect on the direction of AIM ImmunoTech i.e., AIM ImmunoTech and Enbridge go up and down completely randomly.

Pair Corralation between AIM ImmunoTech and Enbridge

Assuming the 90 days trading horizon AIM ImmunoTech is expected to under-perform the Enbridge. In addition to that, AIM ImmunoTech is 4.74 times more volatile than Enbridge. It trades about -0.06 of its total potential returns per unit of risk. Enbridge is currently generating about 0.29 per unit of volatility. If you would invest  4,803  in Enbridge on September 3, 2024 and sell it today you would earn a total of  1,197  from holding Enbridge or generate 24.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy59.38%
ValuesDaily Returns

AIM ImmunoTech  vs.  Enbridge

 Performance 
       Timeline  
AIM ImmunoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Enbridge 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Enbridge are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Enbridge unveiled solid returns over the last few months and may actually be approaching a breakup point.

AIM ImmunoTech and Enbridge Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AIM ImmunoTech and Enbridge

The main advantage of trading using opposite AIM ImmunoTech and Enbridge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AIM ImmunoTech position performs unexpectedly, Enbridge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enbridge will offset losses from the drop in Enbridge's long position.
The idea behind AIM ImmunoTech and Enbridge pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine